Matthew Sherman, M.D., Muscle Disease Section, NIAMS

Contact Information

301-451-9977

9000 Rockville Pike

50 South Drive

Building 50, Room 1142

Bethesda MD 20892

matthew.sherman@nih.gov

Summary

Matthew A. Sherman, M.D., is a clinical fellow who joined the Muscle Disease Unit at NIAMS/NIH in 2021. He is currently completing his pediatric rheumatology fellowship in conjunction with Children’s National Hospital. Dr. Sherman graduated in 2017 from the University of Michigan Medical School, where he joined the Raghavendran Lab investigating the immune dysregulation resulting from traumatic and infectious lung injuries. He completed his pediatrics residency at Children’s National Hospital in 2020.

Research Statement

Dr. Sherman is interested in juvenile idiopathic inflammatory myopathies and specifically those subtypes associated with interstitial lung disease. He is currently working on characterizing the phenotypic patterns of myositis-associated autoantibodies in juvenile IIM and determining what differences exist compared to adults.

Scientific Publications

Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion.

Suresh MV, Thomas B, Dolgachev VA, Sherman MA, Goldberg R, Johnson M, Chowdhury A, Machado-Aranda D, Raghavendran K

Shock.

2016 Oct;

46(4).

doi: 10.1097/SHK.0000000000000601

PMID: 26939039

Double-Stranded RNA Interacts With Toll-Like Receptor 3 in Driving the Acute Inflammatory Response Following Lung Contusion.

Suresh MV, Thomas B, Machado-Aranda D, Dolgachev VA, Kumar Ramakrishnan S, Talarico N, Cavassani K, Sherman MA, Hemmila MR, Kunkel SL, Walter NG, Hogaboam CM, Raghavendran K

Crit Care Med.

2016 Nov;

44(11).

Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α.

Sherman MA, Suresh MV, Dolgachev VA, McCandless LK, Xue X, Ziru L, Machado-Aranda D, Shah YM, Raghavendran K

Ann Surg.

2018 Feb;

267(2).

doi: 10.1097/SLA.0000000000002070

PMID: 27811509

Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia.

Zhang B, Swamy S, Balijepalli S, Panicker S, Mooliyil J, Sherman MA, Parkkinen J, Raghavendran K, Suresh MV

FASEB J.

2019 Dec;

33(12).

doi: 10.1096/fj.201901047RR

PMID: 31530014

Education

Columbia University, School of General Studies
B.A., History (2013)

Jewish Theological Seminary, List College of Jewish Studies
B.A., Talmud and Rabbinics (2013)

University of Michigan Medical School
M.D., with distinction in research (2017)

Clinical Research Training Program, Duke University School of Medicine
Master of Health Sciences in Clinical Research (2021-present)

Experience

Pediatric Residency
Children’s National Hospital (2017-2020)

Pediatric Rheumatology Fellowship
Children’s National Hospital/NIAMS (2020-present)